303 related articles for article (PubMed ID: 12910144)
1. [Strategy of antibiotic therapy in the course of chronic Pseudomonas aeruginosa infection].
Bassinet L
Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S118-28. PubMed ID: 12910144
[No Abstract] [Full Text] [Related]
2. [How should chronic Pseudomonas aeruginosa bronchial infection be treated in the course of cystic fibrosis?].
Hubert D; Desmazes-Dufeu N; Dusser D
Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S129-35. PubMed ID: 12910145
[No Abstract] [Full Text] [Related]
3. Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden.
Knudsen PK; Olesen HV; Høiby N; Johannesson M; Karpati F; Laerum BN; Meyer P; Pressler T; Lindblad A;
J Cyst Fibros; 2009 Mar; 8(2):135-42. PubMed ID: 19157995
[TBL] [Abstract][Full Text] [Related]
4. Aztreonam inhalation solution for suppressive treatment of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis.
Assael BM
Expert Rev Anti Infect Ther; 2011 Nov; 9(11):967-73. PubMed ID: 22029514
[TBL] [Abstract][Full Text] [Related]
5. Approaches to the treatment of initial Pseudomonas aeruginosa infection in children who have cystic fibrosis.
Lahiri T
Clin Chest Med; 2007 Jun; 28(2):307-18. PubMed ID: 17467550
[TBL] [Abstract][Full Text] [Related]
6. [Anti-Pseudomonas aeruginosa (Pa) antibiotic therapy and cystic fibrosis].
Bellon G; Gilly R
Rev Mal Respir; 1991; 8(2):263. PubMed ID: 1907014
[No Abstract] [Full Text] [Related]
7. [Antibiotic inhalation in cystic fibrosis. A review of the literature].
Steinkamp G
Monatsschr Kinderheilkd; 1991 Feb; 139(2):73-80. PubMed ID: 1903843
[TBL] [Abstract][Full Text] [Related]
8. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience.
Hansen CR; Pressler T; Høiby N
J Cyst Fibros; 2008 Nov; 7(6):523-30. PubMed ID: 18693078
[TBL] [Abstract][Full Text] [Related]
9. [Detection and management of early Pseudomonas aeruginosa infection in patients with cystic fibrosis].
Kernen Y; Sauty A; Roulet M
Rev Med Suisse; 2005 Mar; 1(9):637-8, 640. PubMed ID: 15813341
[TBL] [Abstract][Full Text] [Related]
10. Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis.
Ratjen F
Curr Opin Pulm Med; 2006 Nov; 12(6):428-32. PubMed ID: 17053493
[TBL] [Abstract][Full Text] [Related]
11. Eradication of initial Pseudomonas aeruginosa colonization in patients with cystic fibrosis.
Griese M; Müller I; Reinhardt D
Eur J Med Res; 2002 Feb; 7(2):79-80. PubMed ID: 11891148
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of resistant Pseudomonas aeruginosa with elective and rescue intravenous antibiotic regimens in children with cystic fibrosis.
Smyth E; David TJ; Patel L; Ashcroft P; Sanyal D; Vyas J
Int J Antimicrob Agents; 2005 Jul; 26(1):95-6. PubMed ID: 15970432
[No Abstract] [Full Text] [Related]
13. [Intravenous administration of antibiotics in the treatment of cystic fibrosis].
Vávrová V; Lochmann O; Suková B; Copová M; Zapletal A; Absolonová V; Houstĕk J
Cesk Pediatr; 1986 Oct; 41(10):605-7. PubMed ID: 3502950
[No Abstract] [Full Text] [Related]
14. A ten year review of colomycin.
Littlewood JM; Koch C; Lambert PA; Høiby N; Elborn JS; Conway SP; Dinwiddie R; Duncan-Skingle F
Respir Med; 2000 Jul; 94(7):632-40. PubMed ID: 10926333
[No Abstract] [Full Text] [Related]
15. Novel tobramycin inhalation powder in cystic fibrosis subjects: pharmacokinetics and safety.
Geller DE; Konstan MW; Smith J; Noonberg SB; Conrad C
Pediatr Pulmonol; 2007 Apr; 42(4):307-13. PubMed ID: 17352404
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients.
Cantón R; Cobos N; de Gracia J; Baquero F; Honorato J; Gartner S; Alvarez A; Salcedo A; Oliver A; García-Quetglas E;
Clin Microbiol Infect; 2005 Sep; 11(9):690-703. PubMed ID: 16104983
[TBL] [Abstract][Full Text] [Related]
17. Eradication of early Pseudomonas infection in cystic fibrosis.
Lee TW
Chron Respir Dis; 2009; 6(2):99-107. PubMed ID: 19411571
[TBL] [Abstract][Full Text] [Related]
18. Towards zero prevalence of chronic Pseudomonas aeruginosa infection in children with cystic fibrosis.
Lebecque P; Leal T; Zylberberg K; Reychler G; Bossuyt X; Godding V
J Cyst Fibros; 2006 Dec; 5(4):237-44. PubMed ID: 16790367
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial use and Pseudomonas aeruginosa susceptibility profile in a cystic fibrosis centre.
Manno G; Cruciani M; Romano L; Scapolan S; Mentasti M; Lorini R; Minicucci L
Int J Antimicrob Agents; 2005 Mar; 25(3):193-7. PubMed ID: 15737511
[TBL] [Abstract][Full Text] [Related]
20. [Strategy of antibiotic therapy by various routes of administration in the initial colonization by Pseudomonas aeruginosa].
Châtain P
Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S105-12. PubMed ID: 12910142
[No Abstract] [Full Text] [Related]
[Next] [New Search]
